EUVIMEDEUVIMED entdecken
EditorialKommentar

Nemolizumab reduces itch and improves other signs of atopic dermatitis in children aged 6–12 years

British Journal of Dermatology · 2023

DOI: 10.1093/bjd/ljad468 ↗

Kurz gefasst

Editorial in der Zeitschrift British Journal of Dermatology, 2023. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHumansChildDouble-Blind MethodPruritusAntibodies, Monoclonal, Humanized

Substanzen

nemolizumabAntibodies, Monoclonal, Humanized

Zitieren

APA

(2023). Nemolizumab reduces itch and improves other signs of atopic dermatitis in children aged 6–12 years. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad468

Vancouver

Nemolizumab reduces itch and improves other signs of atopic dermatitis in children aged 6–12 years. British Journal of Dermatology. 2023. doi:10.1093/bjd/ljad468

BibTeX
@article{euvimed2023,
  title = {Nemolizumab reduces itch and improves other signs of atopic dermatitis in children aged 6–12 years},
  journal = {British Journal of Dermatology},
  year = {2023},
  doi = {10.1093/bjd/ljad468}
}
Kostenlos starten →